Balancing the Efficacy and Safety of Vaccines in the Elderly
Author:
- 29 June 2012
- journal article
- Published by Bentham Science Publishers Ltd. in Open Longevity Science
- Vol. 6 (1) , 64-72
Abstract
With advances in global health care, ageing populations are expected to grow worldwide throughout the 21st century. Increased lifespan is a testament to modern medical and social practices, but also presents a growing challenge to a system with limited resources. Elderly populations present specific concerns related to preventative health practices, especially vaccination. Although the power of vaccination is unquestionable in controlling infectious disease, immunosenescence can lead to reduced immune responses following immunization in the elderly, and increased morbidity and mortality. Further complicating this issue, some vaccines themselves may pose a substantial safety risk in the elderly when compared to younger counterparts. Though any health care intervention must balance risk and reward, safety and immunogenicity are often poorly characterized in older populations. This review explores several domestic and travel vaccines, examining what is known concerning efficacy and safety in the elderly, and considers future alternatives.Keywords
This publication has 83 references indexed in Scilit:
- The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adultsInfluenza and Other Respiratory Viruses, 2010
- Comparative Efficacy of Inactivated and Live Attenuated Influenza VaccinesNew England Journal of Medicine, 2009
- Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and OlderThe Journal of Infectious Diseases, 2009
- Emulsion-based adjuvants for influenza vaccinesExpert Review of Vaccines, 2009
- Efficacy of pneumococcal vaccination in adults: a meta-analysisCanadian Medical Association Journal, 2009
- Immunity from Smallpox Vaccine Persists for Decades: A Longitudinal StudyThe American Journal of Medicine, 2008
- The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster VaccineThe Journal of Infectious Diseases, 2008
- Strategies for Herpes Zoster Vaccination of Immunocompromised PatientsThe Journal of Infectious Diseases, 2008
- Challenges for vaccination in the elderlyImmunity & Ageing, 2007
- Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjectsVaccine, 2007